ENANTA PHARMACEUTICALS INC Quarterly Operating Lease, Liability in USD from Q3 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Enanta Pharmaceuticals Inc quarterly Operating Lease, Liability history and growth rate from Q3 2019 to Q3 2024.
Enanta Pharmaceuticals Inc Operating Lease, Liability for the quarter ending September 30, 2024 was $55.5M, a 109% increase year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$55.5M	+$29M	+109%	Sep 30, 2024	10-K	2024-11-27
Q2 2024	$50.6M			Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$47M			Mar 31, 2024	10-Q	2024-05-08
Q3 2023	$26.5M	+$1.25M	+4.95%	Sep 30, 2023	10-K	2024-11-27
Q3 2022	$25.3M	+$19.9M	+374%	Sep 30, 2022	10-K	2023-11-22
Q3 2021	$5.33M	-$2.77M	-34.2%	Sep 30, 2021	10-K	2022-11-23
Q3 2020	$8.1M	+$948K	+13.3%	Sep 30, 2020	10-K	2021-11-24
Q2 2020	$8.81M			Jun 30, 2020	10-Q	2020-08-10
Q1 2020	$9.09M			Mar 31, 2020	10-Q	2020-05-11
Q4 2019	$9.12M			Dec 31, 2019	10-Q	2020-02-10
Q3 2019	$7.15M			Oct 1, 2019	10-K	2021-11-24

* An asterisk sign (*) next to the value indicates that the value is likely invalid.